36.65
-0.15 (-0.41%)
Previous Close | 36.80 |
Open | 36.79 |
Volume | 3,556 |
Avg. Volume (3M) | 99,579 |
Market Cap | 7,393,257,984 |
Price / Earnings (TTM) | 28.63 |
Price / Earnings (Forward) | 27.78 |
Price / Sales | 0.550 |
Price / Book | 2.93 |
52 Weeks Range | |
Earnings Date | 27 Aug 2025 |
TTM Dividend Yield | 2.98% |
Profit Margin | 1.95% |
Operating Margin (TTM) | 3.58% |
Diluted EPS (TTM) | 1.29 |
Quarterly Revenue Growth (YOY) | -9.00% |
Quarterly Earnings Growth (YOY) | -18.90% |
Total Debt/Equity (MRQ) | 70.12% |
Current Ratio (MRQ) | 1.22 |
Operating Cash Flow (TTM) | 432.61 M |
Levered Free Cash Flow (TTM) | 338.65 M |
Return on Assets (TTM) | 4.15% |
Return on Equity (TTM) | 10.37% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Distribution (AU) | Mixed | Mixed |
Medical Distribution (Global) | Bearish | Bearish | |
Stock | EBOS FPO NZ [EBO] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 4.0 |
Average | 0.88 |
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations. |
|
Sector | Healthcare |
Industry | Medical Distribution |
Investment Style | Mid Core |
% Held by Insiders | 8.83% |
% Held by Institutions | 25.12% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |